Oral Candidiasis Is Associated with Low Levels of Parotid Calprotectin in Individuals with Infection Due to Human Immunodeficiency Virus

Authors:

Abstract
The level of the antifungal leukocyte protein calprotectin was determined in parotid saliva from 44 individuals with infection due to human immunodeficiency virus (HIV) and 19 healthy HIV-seronegative controls. Nine of the HIV-infected subjects suffered from oral candidiasis. Similar calprotectin levels were found in subjects with HIV infection as a whole group and in controls. When HIV-infected individuals with or without oral candidiasis were compared, the calprotectin level was significantly lower in the former group (67 µg/L vs. 216 µg/L). We suggest that calprotectin may play a role in the defense against oral candidal infections in HIV-infected patients, although several other antimicrobial factors also are probably operative.